CTTH
CTT Pharmaceutical Holdings, Inc.
Price Chart
Latest Quote
$0.07
+0.00 (+4.17%)
Current Price
| Previous Close | $0.07 |
| Open | $0.07 |
| Day High | $0.07 |
| Day Low | $0.07 |
| Volume | 121 |
Stock Information
| Shares Outstanding | 58.66M |
| Total Debt | $19K |
| Cash Equivalents | $15K |
| Net Income | $-156K |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Market Cap | $4.40M |
| Exchange | OQB |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $4.23M |
| Income | $-156K |
| Book/sh | $0.00 |
| Cash/sh | $0.00 |
| Employees | 1 |
Financial Ratios
| Quick Ratio | 0.49 |
| Current Ratio | 0.49 |
| Debt/Eq | 34.11 |
Returns & Margins
| ROA | -99.53% |
| ROE | -357.04% |
Ownership
| Insider Ownership | 50.32% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| P/B | 75.00 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $0.08 |
| SMA50 | $0.07 |
| SMA200 | $0.07 |
| RSI | 54.57 |
| ATR | 0.0035 |
| Shares Float | 28.66M |
| Volatility | 0.71 |
| Rel Volume | 0.01 |
Performance History
| Week | -1.32% |
| Month | -6.25% |
| Quarter | +6.23% |
| 6 Months | +27.66% |
| YTD | +24.11% |
| Year | +275.00% |
| 3 Years | +782.35% |
| 5 Years | +7.91% |
| 10 Years | +150.00% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $0.08 | 121 |
| 2026-06-17 | $0.08 | 5,000 |
| 2026-06-16 | $0.07 | 30,460 |
| 2026-06-15 | $0.07 | 286 |
| 2026-06-12 | $0.08 | 0 |
| 2026-06-11 | $0.08 | 0 |
| 2026-06-10 | $0.08 | 0 |
| 2026-06-09 | $0.08 | 1,000 |
| 2026-06-08 | $0.08 | 0 |
| 2026-06-05 | $0.08 | 0 |
| 2026-06-04 | $0.08 | 11,916 |
| 2026-06-03 | $0.07 | 2,878 |
| 2026-06-02 | $0.07 | 17,525 |
| 2026-06-01 | $0.08 | 2,960 |
| 2026-05-29 | $0.07 | 75,798 |
| 2026-05-28 | $0.07 | 10,000 |
| 2026-05-27 | $0.08 | 12,600 |
| 2026-05-26 | $0.08 | 0 |
| 2026-05-22 | $0.08 | 11,000 |
| 2026-05-21 | $0.08 | 11,250 |
| 2026-05-20 | $0.08 | 49,750 |
| 2026-05-19 | $0.08 | 9,700 |
| 2026-05-18 | $0.08 | 0 |
About CTT Pharmaceutical Holdings, Inc.
CTT Pharmaceutical Holdings, Inc. engages in the development of oral drug delivery systems for pain management and treatment. It focuses on fast dissolving drug delivery systems. The company's technology platform includes the development of advanced oral delivery thin wafers infused with both natural and/or synthetic cannabis extracts to deliver treatment as an alternate to smoking and ingestion. Its principal asset is a patented orally administered dissolvable strip. The company is based in Tampa, Florida.
đ° Latest News
No news articles available at the moment. Check back later for updates on CTTH.
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Revenue | ||
| Total Revenue | $0 | $0 |
| Operating Revenue | $0 | $0 |
| Expenses | ||
| Interest Expense | $1,881 | $0 |
| Total Expenses | $153,903 | $250,229 |
| Net Non Operating Interest Income Expense | $-2,004 | $0 |
| Total Other Finance Cost | $123 | - |
| Interest Expense Non Operating | $1,881 | $0 |
| Operating Expense | $153,903 | $250,229 |
| Other Operating Expenses | $823 | - |
| Selling And Marketing Expense | $7,153 | $0 |
| General And Administrative Expense | $139,495 | $243,831 |
| Income & Earnings | ||
| Net Income From Continuing Operation Net Minority Interest | $-155,907 | $-250,229 |
| Net Interest Income | $-2,004 | $0 |
| Normalized Income | $-155,907 | $-250,229 |
| Net Income From Continuing And Discontinued Operation | $-155,907 | $-250,229 |
| Net Income Common Stockholders | $-155,907 | $-250,229 |
| Net Income | $-155,907 | $-250,229 |
| Net Income Including Noncontrolling Interests | $-155,907 | $-250,229 |
| Net Income Continuous Operations | $-155,907 | $-250,229 |
| Pretax Income | $-155,907 | $-250,229 |
| Operating Income | $-153,903 | $-250,229 |
| Depreciation Amortization Depletion Income Statement | $6,432 | $6,398 |
| Depreciation And Amortization In Income Statement | $6,432 | $6,398 |
| Amortization Of Intangibles Income Statement | $6,432 | $6,398 |
| Per Share | ||
| Diluted EPS | $0.00 | $0.00 |
| Basic EPS | $0.00 | $0.00 |
| Other | ||
| Tax Effect Of Unusual Items | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-147,594 | $-243,831 |
| Reconciled Depreciation | $6,432 | $6,398 |
| EBITDA (Bullshit earnings) | $-147,594 | $-243,831 |
| EBIT | $-154,026 | $-250,229 |
| Diluted Average Shares | $57,571,123 | $52,376,007 |
| Basic Average Shares | $57,571,123 | $52,376,007 |
| Diluted NI Availto Com Stockholders | $-155,907 | $-250,229 |
| Amortization | $6,432 | $6,398 |
| Selling General And Administration | $146,648 | $243,831 |
| Other Gand A | $139,495 | $243,831 |
Fetched: 2026-04-18
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Assets | ||
| Net Tangible Assets | $-15,659 | $-40,745 |
| Total Assets | $86,168 | $73,042 |
| Total Non Current Assets | $70,809 | $72,928 |
| Goodwill And Other Intangible Assets | $70,809 | $72,928 |
| Other Intangible Assets | $70,809 | $72,928 |
| Current Assets | $15,359 | $114 |
| Cash Cash Equivalents And Short Term Investments | $15,359 | $114 |
| Cash And Cash Equivalents | $15,359 | $114 |
| Cash Financial | $15,359 | $114 |
| Debt | ||
| Net Debt | $3,455 | $16,819 |
| Total Debt | $18,814 | $16,933 |
| Current Debt And Capital Lease Obligation | $18,814 | $16,933 |
| Current Debt | $18,814 | $16,933 |
| Liabilities | ||
| Total Liabilities Net Minority Interest | $31,018 | $40,859 |
| Total Non Current Liabilities Net Minority Interest | $0 | $0 |
| Current Liabilities | $31,018 | $40,859 |
| Current Notes Payable | $18,814 | $16,933 |
| Payables And Accrued Expenses | $12,204 | $23,926 |
| Payables | $12,204 | $23,926 |
| Other Payable | $4,904 | - |
| Equity | ||
| Common Stock Equity | $55,150 | $32,183 |
| Total Equity Gross Minority Interest | $55,150 | $32,183 |
| Stockholders Equity | $55,150 | $32,183 |
| Retained Earnings | $-7,551,463 | $-7,395,556 |
| Other | ||
| Ordinary Shares Number | $58,837,232 | $54,069,337 |
| Share Issued | $58,837,232 | $54,069,337 |
| Tangible Book Value | $-15,659 | $-40,745 |
| Invested Capital | $73,964 | $49,116 |
| Working Capital | $-15,659 | $-40,745 |
| Total Capitalization | $55,150 | $32,183 |
| Treasury Stock | $0 | $0 |
| Additional Paid In Capital | $7,600,729 | $7,422,332 |
| Capital Stock | $5,884 | $5,407 |
| Common Stock | $5,884 | $5,407 |
| Dueto Related Parties Current | $7,300 | $23,926 |
Fetched: 2026-04-18
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Free Cash Flow | ||
| Free Cash Flow | $-79,780 | $-228,320 |
| Operating Activities | ||
| Operating Cash Flow | $-75,467 | $-228,320 |
| Cash Flow From Continuing Operating Activities | $-75,467 | $-228,320 |
| Investing Activities | ||
| Capital Expenditure | $-4,313 | - |
| Investing Cash Flow | $-4,313 | $0 |
| Cash Flow From Continuing Investing Activities | $-4,313 | $0 |
| Financing Activities | ||
| Issuance Of Capital Stock | $95,025 | $222,380 |
| Financing Cash Flow | $95,025 | $228,434 |
| Cash Flow From Continuing Financing Activities | $95,025 | $228,434 |
| Net Common Stock Issuance | $95,025 | $222,380 |
| Common Stock Issuance | $95,025 | $222,380 |
| Other | ||
| Repayment Of Debt | $0 | $-10,879 |
| Issuance Of Debt | $0 | $16,933 |
| End Cash Position | $15,359 | $114 |
| Beginning Cash Position | $114 | $0 |
| Changes In Cash | $15,245 | $114 |
| Net Issuance Payments Of Debt | $0 | $6,054 |
| Net Short Term Debt Issuance | $0 | $6,054 |
| Short Term Debt Payments | $0 | $-10,879 |
| Short Term Debt Issuance | $0 | $16,933 |
| Net Intangibles Purchase And Sale | $-4,313 | $0 |
| Purchase Of Intangibles | $-4,313 | $0 |
| Change In Working Capital | $-9,841 | $15,511 |
| Change In Payables And Accrued Expense | $-9,841 | $15,511 |
| Other Non Cash Items | $83,849 | - |
| Depreciation Amortization Depletion | $6,432 | $6,398 |
| Depreciation And Amortization | $6,432 | $6,398 |
| Amortization Cash Flow | $6,432 | $6,398 |
| Amortization Of Intangibles | $6,432 | $6,398 |
| Net Income From Continuing Operations | $-155,907 | $-250,229 |
Fetched: 2026-04-18